Dermata Therapeutics, Inc.DRMANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank82
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P82
Within normal range
vs 2Y Ago
8.8x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 32.96% |
| Q2 2025 | -39.11% |
| Q1 2025 | 33.62% |
| Q4 2024 | 14.78% |
| Q3 2024 | -60.82% |
| Q2 2024 | 21.39% |
| Q1 2024 | -135.72% |
| Q4 2023 | 35.24% |
| Q3 2023 | 3.73% |
| Q2 2023 | -11.56% |
| Q1 2023 | 9.64% |
| Q4 2022 | 28.73% |
| Q3 2022 | -39.24% |
| Q2 2022 | 29.46% |
| Q1 2022 | -44.57% |
| Q4 2021 | 18.38% |
| Q3 2021 | -144.69% |
| Q2 2021 | -16.36% |
| Q1 2021 | -44.82% |
| Q4 2020 | 60.87% |
| Q3 2020 | -84.11% |
| Q2 2020 | 46.06% |
| Q1 2020 | 0.00% |